Results of a multicentre study show that a sequential high-dose chemotherapy variant of the standard treatment is safe and effective in relapsed Hodgkin’s patients.
Related Articles
Cutting Edge
What can we learn from liquid biopsies?
Impact Factor
Are macrophages the bad guys in Hodgkin lymphoma?
Senza categoria